Acurx Pharmaceuticals Inc (ACXP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Operating Expenses | 2,029 | 2,270 | 2,149 | 2,776 | 2,827 |
| Operating Income | -2,029 | -2,270 | -2,149 | -2,776 | -2,827 |
| Other Income | 36 | 23 | 0 | -6 | 5 |
| Pre-tax Income | -1,993 | -2,246 | -2,149 | -2,782 | -2,822 |
| Net Income Continuous | -1,993 | -2,246 | -2,149 | -2,782 | -2,822 |
| Net Income | $-1,993 | $-2,246 | $-2,149 | $-2,782 | $-2,822 |
| EPS Basic Total Ops | -1.23 | -1.89 | -2.20 | -3.14 | -3.45 |
| EPS Basic Continuous Ops | -1.23 | -1.89 | -2.15 | -3.13 | -3.45 |
| EPS Diluted Total Ops | -1.23 | -1.89 | -2.20 | -3.14 | -3.45 |
| EPS Diluted Continuous Ops | -1.23 | -1.89 | -2.15 | -3.13 | -3.45 |
| EPS Diluted Before Non-Recurring Items | -1.23 | -1.89 | -2.20 | -3.20 | -3.40 |
| EBITDA(a) | $-2,029 | $-2,270 | $-2,149 | $-2,776 | $-2,827 |